🇺🇸 FDA

Intelligence · Clinical Pipeline

Takeda Pipeline

All ClinicalTrials.gov programs at Takeda — phase, modality, and trial IDs.

Programs
276

Quick answer

Takeda has 276 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. TAK-438ASA

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  2. TAK-491

    Takeda

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  3. TAK-510

    Takeda

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  4. TAK-536

    Takeda

    Japanese Healthy Adult Male Participants

    phase 1 small molecule completed

    1 trial

  5. TAK-536

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  6. TAK-536 Tablet

    Takeda

    Japanese Healthy Adult Males

    phase 1 small molecule completed

    1 trial

  7. TAK-536TCH

    Takeda

    Hypertension

    phase 1 small molecule completed

    1 trial

  8. TAK-580

    Takeda

    Melanoma

    phase 1 small molecule terminated

    1 trial

  9. TAK-648

    Takeda

    Type 2 Diabetes Mellitus

    phase 1 small molecule completed

    1 trial

  10. TAK-648

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  11. TAK-648 Tablet

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  12. TAK-659

    Takeda

    Lymphoma, Non-Hodgkin

    phase 1 small molecule terminated

    1 trial

  13. TAK-671

    Takeda

    Coronavirus Disease

    phase 1 small molecule terminated

    1 trial

  14. TAK-676

    Takeda

    Head and Neck Squamous Cell Carcinoma

    phase 1 small molecule completed

    1 trial

  15. TAK-755

    Takeda

    Sickle Cell Disease

    phase 1 small molecule completed

    1 trial

  16. TAK-781

    Takeda

    Healthy Volunteers

    phase 1 small molecule active

    1 trial

  17. TAK-788

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    3 trials

  18. TAK-792 30 mg

    Takeda

    Healthy Male Adults Participants

    phase 1 small molecule completed

    1 trial

  19. TAK-828

    Takeda

    Healthy Volunteers

    phase 1 small molecule terminated

    1 trial

  20. TAK-828

    Takeda

    Dose Finding Study

    phase 1 small molecule completed

    1 trial

  21. TAK-861, TAK-861, TAK-861

    Takeda

    Narcolepsy with Cataplexy (Narcolepsy Type 1)

    phase 1 small molecule active

    1 trial

  22. TAK-875 and Glimepiride

    Takeda

    Pharmacokinetics

    phase 1 small molecule completed

    1 trial

  23. TAK-881

    Takeda

    Healthy Volunteers

    phase 1 mab completed

    3 trials

  24. TAK-906

    Takeda

    Japanese Healthy Adult Male Participants

    phase 1 small molecule completed

    1 trial

  25. TAK-906

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    3 trials

  26. TAK-906 Maleate

    Takeda

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  27. TAK-906 Oral Capsule

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  28. TAK-915

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  29. TAK-915 suspension

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  30. TAK-925

    Takeda

    Obstructive Sleep Apnea

    phase 1 small molecule completed

    1 trial

  31. TAK-925

    Takeda

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  32. TAK-925

    Takeda

    Healthy Participants and Patients With Narcolepsy

    phase 1 small molecule completed

    1 trial

  33. TAK-925

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  34. TAK-925

    Takeda

    Idiopathic Hypersomnia

    phase 1 small molecule completed

    1 trial

  35. TAK-931

    Takeda

    Nonhematologic Neoplasms, Advanced

    phase 1 small molecule completed

    1 trial

  36. TAK-931 PIC

    Takeda

    Neoplasms, Advanced Solid

    phase 1 small molecule completed

    1 trial

  37. TAK-935

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  38. TAK-935

    Takeda

    Epilepsy, Molecular Mechanisms of Pharmalogical Action, Protective Agents

    phase 1 small molecule completed

    1 trial

  39. TAK-935

    Takeda

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  40. TAK-935 Oral Tablet

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  41. TAK-935 Tablets

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  42. TAK-951

    Takeda

    Healthy Volunteers

    phase 1 small molecule terminated

    1 trial

  43. TAK-951

    Takeda

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  44. TAK-951

    Takeda

    Nausea and Vomitting

    phase 1 small molecule terminated

    1 trial

  45. TAK-951 Placebo

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  46. TAK-954

    Takeda

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  47. TAK-954

    Takeda

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  48. TAK-954

    Takeda

    Renal Impairment

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many pipeline programs does Takeda have?

276 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.